Breyanzi

lisocabtagene maraleucel · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Breyanzi, covering 2024-08-15 to 2026-08-06. Get the full timeline:

Most recent: EMA Authorised: Breyanzi (lisocabtagene maraleucel) — Bristol-Myers Squibb Pharma EEIG